Blood Plasma Donors For COVID-19 Treatment Will Receive Remuneration - Moscow Authorities

Table of contents:

Blood Plasma Donors For COVID-19 Treatment Will Receive Remuneration - Moscow Authorities
Blood Plasma Donors For COVID-19 Treatment Will Receive Remuneration - Moscow Authorities

Video: Blood Plasma Donors For COVID-19 Treatment Will Receive Remuneration - Moscow Authorities

Отличия серверных жестких дисков от десктопных
Video: S. Korea urges COVID-19 survivors to donate blood plasma for future treatment 2023, January
Anonim

Blood plasma donors for COVID-19 treatment will receive remuneration - Moscow authorities

Citizens from 18 to 55 years old who have recovered from coronavirus and who do not have chronic diseases, HIV and hepatitis can donate their plasma.

Blood plasma donors for COVID-19 treatment will receive remuneration - Moscow authorities
Blood plasma donors for COVID-19 treatment will receive remuneration - Moscow authorities

Photo: Central Bank of the Russian Federation

Citizens from 18 to 55 years old who have recovered from coronavirus and who do not have chronic diseases, HIV and hepatitis can donate their plasma.

In the near future, Moscow will adopt regulations governing the procedure and amount of remuneration, Vice Mayor Anastasia Rakova told reporters. A hotline has now been launched on plasma donation for the treatment of coronavirus, “About 100-150 people are cured of infection every day. Now there are about 1,500 such people, which means that there are potential donors in Moscow. I am making a request to these people. Our doctors helped you to cope with the infection - you can help those who are now in the hospital,”the vice-mayor addressed the townspeople.

A blood plasma donor can be a person who recovered from COVID-19 from 18 to 55 years old, who has a negative test for HIV, hepatitis B and C.

The plasma donation hotline is open daily from 9:00 to 19:00 by phone 8 (495) 870-45-16.

The purpose of a plasma transfusion is to transfer the antibodies from the blood of a recovered person to a patient in the acute phase of the disease. Scientists call this method "passive antibody therapy" because the person receives external antibodies, and does not generate an immune response on their own, as after vaccination.

Plasma transfusion has been used with varying success in the SARS outbreak in Hong Kong and during the Ebola epidemic in Africa. The effectiveness of this method in the treatment of COVID-19 has not yet been fully studied, however, Johns Hopkins University immunologist Arturo Casadevall insists on its distribution.

Popular by topic